Artificial intelligence uncovers carcinogenic human metabolites

Aayushi Mittal1, Sanjay Kumar Mohanty1, Vishakha Gautam1

  • 1Department of Computational Biology, Indraprastha Institute of Information Technology-Delhi, Okhla, Phase III, New Delhi, Delhi, India.

Nature Chemical Biology
|August 11, 2022
PubMed

Insights

Metabokiller accurately predicts carcinogens by analyzing cellular damage indicators. This new tool identifies potential human carcinogens and is validated by lab experiments.

Area of Science:

  • Genomics
  • Toxicology
  • Computational Biology

Background:

  • Eukaryotic genomes face constant threats from various compounds, potentially leading to malignant transformation despite DNA repair mechanisms.
  • Accurate prediction of carcinogens remains challenging due to limited data on known carcinogens and non-carcinogens.

Purpose of the Study:

  • To develop an accurate and interpretable carcinogen prediction tool named Metabokiller.
  • To identify potential carcinogenic human metabolites using the developed classifier.

Main Methods:

  • Developed Metabokiller, an ensemble classifier assessing electrophilicity, proliferation, oxidative stress, genomic instability, epigenome alterations, and anti-apoptotic responses.
  • Validated predictions using functional assays in Saccharomyces cerevisiae and human cells with flagged metabolites (4-nitrocatechol, 3,4-dihydroxyphenylacetic acid).

Main Results:

  • Metabokiller accurately recognizes carcinogens and outperforms existing prediction methods.
  • The tool identified potential carcinogenic human metabolites.
  • Experimental validations showed high synergy with Metabokiller predictions for flagged metabolites.

Conclusions:

  • Metabokiller offers a robust and interpretable approach to carcinogen prediction.
  • The study highlights potential risks associated with specific human metabolites.
  • The findings pave the way for improved toxicological assessments and cancer prevention strategies.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K